CHMP recommends oral peanut allergy immunotherapy treatment for toddlers
The EMA’s CHMP has endorsed expanding the use of Palforzia to toddlers aged one to three years with peanut allergies.
The EMA’s CHMP has endorsed expanding the use of Palforzia to toddlers aged one to three years with peanut allergies.
What's Your Reaction?
